Howard Hughes (HHH) Competitors $73.29 -0.46 (-0.62%) Closing price 03:59 PM EasternExtended Trading$73.75 +0.46 (+0.63%) As of 04:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HHH vs. TSHA, ZG, WPC, HLI, REG, GLPI, AMH, JEF, DOC, and HSTShould you be buying Howard Hughes stock or one of its competitors? The main competitors of Howard Hughes include Taysha Gene Therapies (TSHA), Zillow Group (ZG), W.P. Carey (WPC), Houlihan Lokey (HLI), Regency Centers (REG), Gaming and Leisure Properties (GLPI), American Homes 4 Rent (AMH), Jefferies Financial Group (JEF), Healthpeak Properties (DOC), and Host Hotels & Resorts (HST). Howard Hughes vs. Its Competitors Taysha Gene Therapies Zillow Group W.P. Carey Houlihan Lokey Regency Centers Gaming and Leisure Properties American Homes 4 Rent Jefferies Financial Group Healthpeak Properties Host Hotels & Resorts Howard Hughes (NYSE:HHH) and Taysha Gene Therapies (NASDAQ:TSHA) are related companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, dividends, analyst recommendations, earnings and valuation. Is HHH or TSHA more profitable? Howard Hughes has a net margin of 12.85% compared to Taysha Gene Therapies' net margin of -1,144.97%. Howard Hughes' return on equity of 10.51% beat Taysha Gene Therapies' return on equity.Company Net Margins Return on Equity Return on Assets Howard Hughes12.85% 10.51% 3.15% Taysha Gene Therapies -1,144.97%-78.44%-44.82% Does the media prefer HHH or TSHA? In the previous week, Taysha Gene Therapies had 15 more articles in the media than Howard Hughes. MarketBeat recorded 27 mentions for Taysha Gene Therapies and 12 mentions for Howard Hughes. Howard Hughes' average media sentiment score of 1.06 beat Taysha Gene Therapies' score of 0.05 indicating that Howard Hughes is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Howard Hughes 8 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Taysha Gene Therapies 2 Very Positive mention(s) 4 Positive mention(s) 12 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend HHH or TSHA? Howard Hughes presently has a consensus price target of $80.33, indicating a potential upside of 9.55%. Taysha Gene Therapies has a consensus price target of $8.29, indicating a potential upside of 182.11%. Given Taysha Gene Therapies' stronger consensus rating and higher probable upside, analysts clearly believe Taysha Gene Therapies is more favorable than Howard Hughes.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Howard Hughes 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Taysha Gene Therapies 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility and risk, HHH or TSHA? Howard Hughes has a beta of 1.22, indicating that its share price is 22% more volatile than the S&P 500. Comparatively, Taysha Gene Therapies has a beta of 0.98, indicating that its share price is 2% less volatile than the S&P 500. Which has better earnings & valuation, HHH or TSHA? Howard Hughes has higher revenue and earnings than Taysha Gene Therapies. Taysha Gene Therapies is trading at a lower price-to-earnings ratio than Howard Hughes, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHoward Hughes$1.75B2.49$200.55M$4.5716.05Taysha Gene Therapies$8.33M75.69-$89.30M-$0.34-8.64 Do insiders & institutionals believe in HHH or TSHA? 93.8% of Howard Hughes shares are held by institutional investors. Comparatively, 77.7% of Taysha Gene Therapies shares are held by institutional investors. 33.0% of Howard Hughes shares are held by company insiders. Comparatively, 3.8% of Taysha Gene Therapies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryHoward Hughes beats Taysha Gene Therapies on 11 of the 16 factors compared between the two stocks. Get Howard Hughes News Delivered to You Automatically Sign up to receive the latest news and ratings for HHH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HHH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HHH vs. The Competition Export to ExcelMetricHoward HughesREAL ESTATE DEV IndustryFinance SectorNYSE ExchangeMarket Cap$4.36B$2.76B$12.33B$20.93BDividend YieldN/A2.76%5.56%3.59%P/E Ratio16.0511.5719.5528.18Price / Sales2.493.2525.7656.89Price / Cash7.6127.2118.7717.81Price / Book1.291.042.254.57Net Income$200.55M-$106.17M$1.01B$993.62M7 Day Performance4.16%2.71%1.20%2.33%1 Month Performance6.77%9.21%0.84%1.41%1 Year Performance1.93%2.58%543.78%13.75% Howard Hughes Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HHHHoward Hughes2.2677 of 5 stars$73.29-0.6%$80.33+9.6%+2.5%$4.35B$1.75B16.04608News CoverageTSHATaysha Gene Therapies3.483 of 5 stars$2.76+1.5%$8.17+195.9%+30.7%$583.88M$8.33M-8.12180Earnings ReportAnalyst RevisionZGZillow Group4.0963 of 5 stars$76.12-1.8%$85.62+12.5%+57.2%$18.71B$2.24B-292.776,856Trending NewsInsider TradeShort Interest ↓WPCW.P. Carey3.2226 of 5 stars$65.60-0.4%$65.00-0.9%+13.8%$14.43B$1.58B43.16190News CoveragePositive NewsAnalyst ForecastShort Interest ↑HLIHoulihan Lokey4.6468 of 5 stars$190.34+0.8%$206.40+8.4%+24.9%$13.18B$2.39B32.041,100Positive NewsShort Interest ↓REGRegency Centers4.5002 of 5 stars$71.54-0.5%$77.92+8.9%+1.8%$13.06B$1.45B33.43440Positive NewsAnalyst ForecastGLPIGaming and Leisure Properties4.7241 of 5 stars$45.54-0.8%$53.16+16.7%-6.0%$12.99B$1.53B17.6520Positive NewsAMHAmerican Homes 4 Rent4.1721 of 5 stars$34.23-0.6%$40.90+19.5%-9.1%$12.77B$1.73B30.831,730News CoveragePositive NewsJEFJefferies Financial Group4.2916 of 5 stars$58.89+0.7%$66.00+12.1%+4.8%$12.06B$7.03B22.227,822DOCHealthpeak Properties4.7098 of 5 stars$16.79-1.0%$23.00+37.0%-19.4%$11.79B$2.70B69.94200Positive NewsDividend AnnouncementHSTHost Hotels & Resorts4.4318 of 5 stars$15.31-0.3%$17.50+14.3%-4.4%$10.55B$5.68B16.29160Positive News Related Companies and Tools Related Companies Taysha Gene Therapies Competitors Zillow Group Competitors W.P. Carey Competitors Houlihan Lokey Competitors Regency Centers Competitors Gaming and Leisure Properties Competitors American Homes 4 Rent Competitors Jefferies Financial Group Competitors Healthpeak Properties Competitors Host Hotels & Resorts Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:HHH) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Howard Hughes Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Howard Hughes With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access